Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ABT

Abbott Laboratories

Healthcare · USD

Set alert

Price alert · ABT

All alert types
106.20 USD +1.63 +1.56%
As of Oct 30, 2026 Extended hours 106.25 +0.05%
Bid
106.19 × 400
Ask
106.27 × 100
104.60 Day range 106.85
82.56 52-week range 130.59
YTD
-15.24%
1 year
-14.82%
Open
106.15
Prev close
104.57
Mkt cap
184.98B
Vol
8.44M
Avg vol
8.76M
EPS
2.69
P/E
39.48
Div yield
2.41%
More statistics
Low
104.60
High
106.85
Forward P/E
17.89
Beta
0.58
Short ratio
1.84
Inst. own
81.90%
Dividend
2.52
Ex-div date
Oct 14, 2026
Earnings
Jan 28, 2027
50-d avg
104.50
200-d avg
101.79
1y target
118.52

5D chart

Chart tools
Interval
1m5m15m30m
ABT five-day price chart101.5102.9104.2105.5106.8Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

3.29 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 2
  • P/B 1

Valuation

P/E 33.5×
FY 2016: 40.4×FY 2017: 211×FY 2018: 53.6×FY 2019: 42.0×FY 2020: 43.4×FY 2021: 35.5×FY 2022: 27.9×FY 2023: 33.4×FY 2024: 14.7×FY 2025: 33.5×
FY 2016 5y median 33.4× FY 2025
P/S 4.9×
FY 2016: 2.7×FY 2017: 3.6×FY 2018: 4.2×FY 2019: 4.8×FY 2020: 5.6×FY 2021: 5.8×FY 2022: 4.4×FY 2023: 4.8×FY 2024: 4.7×FY 2025: 4.9×
FY 2016 5y median 4.8× FY 2025
P/B 4.2×
FY 2016: 2.8×FY 2017: 3.2×FY 2018: 4.2×FY 2019: 4.9×FY 2020: 5.9×FY 2021: 7.0×FY 2022: 5.2×FY 2023: 4.9×FY 2024: 4.1×FY 2025: 4.2×
FY 2016 5y median 4.9× FY 2025
P/FCF 29.6×
FY 2016: 27.2×FY 2017: 22.4×FY 2018: 25.9×FY 2019: 34.1×FY 2020: 33.9×FY 2021: 28.9×FY 2022: 24.7×FY 2023: 37.7×FY 2024: 30.8×FY 2025: 29.6×
FY 2016 5y median 29.6× FY 2025
EV/EBITDA 18.9×
FY 2016: 19.5×FY 2017: 19.2×FY 2018: 20.7×FY 2019: 21.3×FY 2020: 23.0×FY 2021: 21.3×FY 2022: 16.9×FY 2023: 18.8×FY 2024: 18.8×FY 2025: 18.9×
FY 2016 5y median 18.8× FY 2025
EV/Sales 5.1×
FY 2016: 2.9×FY 2017: 4.3×FY 2018: 4.7×FY 2019: 5.3×FY 2020: 6.0×FY 2021: 6.0×FY 2022: 4.6×FY 2023: 5.0×FY 2024: 4.9×FY 2025: 5.1×
FY 2016 5y median 5.0× FY 2025
FCF Yield 3.4%
FY 2016: 3.7%FY 2017: 4.5%FY 2018: 3.9%FY 2019: 2.9%FY 2020: 2.9%FY 2021: 3.5%FY 2022: 4.1%FY 2023: 2.7%FY 2024: 3.2%FY 2025: 3.4%
FY 2016 5y median 3.4% FY 2025

Profitability

Gross Margin 55.5%
FY 2016: 53.9%FY 2017: 47.7%FY 2018: 51.7%FY 2019: 52.3%FY 2020: 50.2%FY 2021: 53.9%FY 2022: 51.1%FY 2023: 50.0%FY 2024: 50.8%FY 2025: 55.5%
FY 2016 5y median 51.1% FY 2025
Operating Margin 18.2%
FY 2016: 15.6%FY 2017: 7.2%FY 2018: 12.6%FY 2019: 14.4%FY 2020: 15.3%FY 2021: 21.4%FY 2022: 19.2%FY 2023: 16.0%FY 2024: 16.3%FY 2025: 18.2%
FY 2016 5y median 18.2% FY 2025
Net Margin 14.7%
FY 2016: 6.7%FY 2017: 1.7%FY 2018: 7.7%FY 2019: 11.6%FY 2020: 13.0%FY 2021: 16.4%FY 2022: 15.9%FY 2023: 14.3%FY 2024: 31.9%FY 2025: 14.7%
FY 2016 5y median 15.9% FY 2025
ROE 12.5%
FY 2016: 6.8%FY 2017: 1.5%FY 2018: 7.8%FY 2019: 11.9%FY 2020: 13.7%FY 2021: 19.8%FY 2022: 18.9%FY 2023: 14.8%FY 2024: 28.1%FY 2025: 12.5%
FY 2016 5y median 18.9% FY 2025
ROIC 8.4%
FY 2016: 4.9%FY 2017: 0.5%FY 2018: 5.4%FY 2019: 7.1%FY 2020: 7.8%FY 2021: 12.6%FY 2022: 11.4%FY 2023: 9.1%FY 2024: 9.9%FY 2025: 8.4%
FY 2016 5y median 9.9% FY 2025
ROA 7.5%
FY 2016: 2.5%FY 2017: 0.6%FY 2018: 3.5%FY 2019: 5.4%FY 2020: 6.2%FY 2021: 9.4%FY 2022: 9.3%FY 2023: 7.8%FY 2024: 16.5%FY 2025: 7.5%
FY 2016 5y median 9.3% FY 2025

Growth (YoY)

Revenue 5.7%
FY 2016: 2.2%FY 2017: 31.3%FY 2018: 11.6%FY 2019: 4.3%FY 2020: 8.5%FY 2021: 24.5%FY 2022: 1.3%FY 2023: -8.1%FY 2024: 4.6%FY 2025: 5.7%
FY 2016 FY 2025
Operating Income 17.9%
FY 2016: 10.2%FY 2017: -39.3%FY 2018: 94.9%FY 2019: 19.4%FY 2020: 15.2%FY 2021: 73.9%FY 2022: -9.1%FY 2023: -23.0%FY 2024: 6.1%FY 2025: 17.9%
FY 2016 FY 2025
EPS (diluted) -51.3%
FY 2016: -68.0%FY 2017: -71.3%FY 2018: 396.3%FY 2019: 53.7%FY 2020: 21.4%FY 2021: 57.6%FY 2022: -0.8%FY 2023: -16.4%FY 2024: 133.6%FY 2025: -51.3%
FY 2016 FY 2025
Free Cash Flow 16.4%
FY 2016: 12.2%FY 2017: 113.0%FY 2018: 10.6%FY 2019: -8.3%FY 2020: 27.3%FY 2021: 51.1%FY 2022: -9.8%FY 2023: -35.2%FY 2024: 25.5%FY 2025: 16.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 4.0×FY 2017: 2.3×FY 2018: 1.6×FY 2019: 1.4×FY 2020: 1.7×FY 2021: 1.8×FY 2022: 1.6×FY 2023: 1.6×FY 2024: 1.7×FY 2025: 1.6×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 1.2×
FY 2016: 3.7×FY 2017: 1.9×FY 2018: 1.2×FY 2019: 1.0×FY 2020: 1.3×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
Debt / Equity 0.3×
FY 2016: 1.1×FY 2017: 0.9×FY 2018: 0.6×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 1.1×FY 2017: 3.0×FY 2018: 2.3×FY 2019: 1.9×FY 2020: 1.4×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.8×FY 2024: 0.7×FY 2025: 0.5×
FY 2016 5y median 0.7× FY 2025
Interest Coverage 23.6×
FY 2016: 10.7×FY 2017: 2.2×FY 2018: 5.3×FY 2019: 5.6×FY 2020: 7.5×FY 2021: 22.4×FY 2022: 26.5×FY 2023: 9.2×FY 2024: 11.3×FY 2025: 23.6×
FY 2016 5y median 22.4× FY 2025

Dividends

Dividend Yield 1.9%
FY 2016: 2.7%FY 2017: 1.9%FY 2018: 1.6%FY 2019: 1.5%FY 2020: 1.3%FY 2021: 1.3%FY 2022: 1.7%FY 2023: 1.9%FY 2024: 2.0%FY 2025: 1.9%
FY 2016 5y median 1.9% FY 2025
Payout Ratio 63.1%
FY 2016: 109.9%FY 2017: 387.6%FY 2018: 83.4%FY 2019: 61.6%FY 2020: 57.0%FY 2021: 45.3%FY 2022: 47.7%FY 2023: 62.1%FY 2024: 28.6%FY 2025: 63.1%
FY 2016 5y median 47.7% FY 2025

Annual · latest fiscal year ends 2025-12-31